ctrl K

Day One Biopharmaceutical... (DAWN)

NASDAQ: DAWN · Real-Time Price · USD

7.63

-0.15 (-1.93%)

At close: May 01, 2025, 3:59 PM

7.75

1.51%

Pre-market: May 02, 2025, 08:29 AM EDT

Day One Biopharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	131.16M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	5.28M	383K	531K	199K	155K	n/a
Gross Profit	125.88M	-383K	-531K	-199K	-155K	n/a
Operating Income	-217.27M	-206.06M	-146.91M	-72.74M	-13.78M	-14.9M
Interest Income	n/a	17.19M	4.75M	4K	30.00	2.08K
Pretax Income	-88.35M	-188.92M	-142.18M	-72.75M	-43.84M	-16.98M
Net Income	-95.5M	-188.92M	-132.18M	-70.44M	-40.51M	-14.71M
Selling & General & Admin	115.45M	75.54M	61.29M	29.16M	4.68M	1.01M
Research & Development	227.7M	130.52M	85.62M	43.58M	9.1M	13.9M
Other Expenses	n/a	1.00	-18K	-15K	-31K	-2K
Operating Expenses	343.15M	206.06M	146.91M	72.74M	13.78M	14.9M
Interest Expense	n/a	n/a	4.75M	4K	30K	2.08M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	348.43M	206.06M	146.91M	72.74M	13.78M	14.9M
Income Tax Expense	-7.14M	n/a	-10.01M	-2.31M	-3.34M	-2.27M
Shares Outstanding (Basic)	93.62M	79.77M	65.47M	61.95M	61.93M	61.93M
Shares Outstanding (Diluted)	93.62M	79.77M	65.47M	61.95M	61.93M	61.93M
EPS (Basic)	-1.02	-2.37	-2.02	-1.14	-0.65	-0.24
EPS (Diluted)	-1.02	-2.37	-2.02	-1.14	-0.65	-0.24
EBITDA	-217.27M	-206.06M	-141.65M	-72.56M	-43.66M	-2K
EBIT	n/a	-206.06M	-146.91M	-72.75M	-13.78M	-14.91M
Depreciation & Amortization	n/a	383K	531K	199K	155K	14.9M